Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2011 1
2020 1
2021 4
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction.
Trombara F, Cosentino N, Bonomi A, Ludergnani M, Poggio P, Gionti L, Baviera M, Colacioppo P, Roncaglioni MC, Leoni O, Bortolan F, Agostoni P, Genovese S, Marenzi G. Trombara F, et al. Among authors: colacioppo p. Cardiovasc Diabetol. 2023 Feb 6;22(1):26. doi: 10.1186/s12933-023-01758-y. Cardiovasc Diabetol. 2023. PMID: 36747186 Free PMC article.
Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
Ojeda-Fernández L, Foresta A, Macaluso G, Colacioppo P, Tettamanti M, Zambon A, Genovese S, Fortino I, Leoni O, Roncaglioni MC, Baviera M. Ojeda-Fernández L, et al. Among authors: colacioppo p. Diabetes Obes Metab. 2022 May;24(5):891-898. doi: 10.1111/dom.14648. Epub 2022 Jan 25. Diabetes Obes Metab. 2022. PMID: 35014746
Insulin treatment in patients with diabetes mellitus and heart failure in the era of new antidiabetic medications.
Staszewsky L, Baviera M, Tettamanti M, Colacioppo P, Robusto F, D'Ettorre A, Lepore V, Fortino I, Bisceglia L, Attolini E, Graps EA, Caldo G, Roncaglioni MC, Garattini S, Latini R. Staszewsky L, et al. Among authors: colacioppo p. BMJ Open Diabetes Res Care. 2022 Mar;10(2):e002708. doi: 10.1136/bmjdrc-2021-002708. BMJ Open Diabetes Res Care. 2022. PMID: 35351688 Free PMC article.
Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts.
Baviera M, Genovese S, Lepore V, Colacioppo P, Robusto F, Tettamanti M, D'Ettorre A, Avanzini F, Fortino I, Nicolucci A, Roncaglioni MC, Giorgino F. Baviera M, et al. Among authors: colacioppo p. Diabetes Obes Metab. 2021 Jul;23(7):1484-1495. doi: 10.1111/dom.14361. Epub 2021 Mar 15. Diabetes Obes Metab. 2021. PMID: 33606897
Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study.
Proietti M, Marzona I, Vannini T, Colacioppo P, Tettamanti M, Foresta A, Fortino I, Merlino L, Lip GYH, Roncaglioni MC. Proietti M, et al. Among authors: colacioppo p. Eur Heart J Cardiovasc Pharmacother. 2021 Apr 9;7(FI1):f84-f92. doi: 10.1093/ehjcvp/pvaa015. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 32129845 Free article.
13 results